Brookstone Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Brookstone Capital Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14,868	Closed	-$967K	–	800
2022 Q2	$967K	Buy	+14,868	New	+$944K	0.02%	411
2015 Q4	–	Sell	-331,194	Closed	-$16.3M	–	497
2015 Q3	$16.3M	Sell	331,194 -597	-0.2%	-$34.2K	2.96%	10
2015 Q2	$19.3M	Buy	331,791 +14,223	+4%	+$831K	2.43%	4
2015 Q1	$18.3M	Buy	317,568 +8,469	+3%	+$463K	2.76%	7
2014 Q4	$15.6M	Buy	+309,099	New	+$15.1M	2.59%	8

Other funds holding IHE

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Brookstone Capital Management's IHE Position: Q3 2022 in Review

Brookstone Capital Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2022, closing a stake of 14,868 shares — an estimated $967K sold.

Brookstone Capital Management first reported a position in IHE in Q4 2014 and held it in 5 quarters. The position peaked at $19.3M in Q2 2015. 113 funds tracked by Wall St. Rank hold IHE as of Q3 2022.

Brookstone Capital Management reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2022 after selling out during the quarter.
Brookstone Capital Management sold 14,868 iShares US Pharmaceuticals ETF shares in Q3 2022, an estimated $967K.
Brookstone Capital Management first reported a position in iShares US Pharmaceuticals ETF in Q4 2014 and held it in 5 quarters.
Brookstone Capital Management's iShares US Pharmaceuticals ETF position peaked at $19.3M in Q2 2015.
113 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2022.

Based on Brookstone Capital Management's 13F filing for Q3 2022, filed 14 Oct 2022.